首页> 外文会议>World biomaterials congress >Egg shell derived hydroxyapatite as bone graft material in maxillofacial skeleton - A randomized blind multi-center clinical trial
【24h】

Egg shell derived hydroxyapatite as bone graft material in maxillofacial skeleton - A randomized blind multi-center clinical trial

机译:蛋壳来源的羟基磷灰石作为颌面部骨骼的骨移植材料-随机多中心盲临床试验

获取原文

摘要

Background: The grafting of bone for enhancement of bone regeneration is known since long time. In maxillofacial skeleton after cystic removal, bony defects and impacted tooth usually the grafting will be done to prevent complications and enhance the bone regeneration. Various bone regenerative materials have been used with varying degree of success.Because of advancement in the Biomaterial technology the regenerative science has changed its face. Emerging technology made it possible to use egg shell waste as raw material to produce HA. The HA prepared from egg shell waste as shown promising in vitro results. The studies with EHA is emerging with promising results in very economical way.So the study has been planned to assess efficacy of EHA in maxillofacial skeleton. Aim and Objectives: Aim of the study is to evaluate the effectiveness of Egg shell derived hydroxyapatite (EHA) as graft material in the enhancement of bone regeneration after removal of impacted third molar. The osseous fill was assessed using digital radiographs and clinical evaluation of gingival attachment measured. Material and Methods: Twenty patients (ten patients in each center) enrolled for the pilot study. A split mouth randomized case control blind multicenter protocol followed to test efficacy of the EHA. After surgical removal of bilateral impacted third molars using standard operating protocol, case site was grafted with indigenously prepared EHA and other left unfilled as control. The patients were followed up at 1st and 2nd week post operatively for signs or symptoms of infection or any other complications related to the procedure. Radiographic observations were done at 1st, 3rd and 6th month post surgically to assess the amount of osseous fill. The observers were blinded both for time duration of follow-up and surgical procedure. Results: Wound healing was uneventful in all the patients. The clinical attachment level and bone formation in grafted sites were significantly higher than the control sites. Both centers showed similar bone formation. Conclusion: This multicenter pilot study results showed promising results with EHA. The enhancement of bone formation was observed in comparison with control group. EHA will emerge as economic, safe synthetic graft material for grafting in maxillofacial skeleton. The process of preparation of EHA is go green. The Egg shell waste is valuable raw material for EHA production in cost effective way with no disease transfer risks.
机译:背景:长期以来,为了增强骨骼再生而进行的植骨是众所周知的。在囊性切除,颌骨缺损和牙齿受累后,通常在颌面部骨骼中进行嫁接,以防止并发症并增强骨骼再生。已经使用了各种骨再生材料,并取得了不同程度的成功。由于生物材料技术的进步,再生科学改变了它的面貌。新兴技术使得利用蛋壳废料生产HA成为可能。从卵壳​​废料制备的HA具有令人满意的体外结果。 EHA的研究正在以非常经济的方式获得有希望的结果。因此,该研究计划用于评估EHA在颌面部骨骼中的疗效。目的和目的:本研究的目的是评估蛋壳衍生的羟基磷灰石(EHA)作为移植材料在去除受影响的第三磨牙后增强骨再生的有效性。使用数字X射线照片评估骨填充,并测量牙龈附着的临床评估。材料和方法:20名患者(每个中心10名患者)参加了该初步研究。随后进行了一项口腔随机病例对照盲多中心试验,以测试EHA的疗效。在使用标准操作规程手术切除双侧受影响的第三磨牙后,将病例部位与本地准备的EHA嫁接,其余未填充的作为对照。术后第一周和第二周对患者进行随访,检查是否有感染的体征或症状或与手术相关的任何其他并发症。在手术后的第1、3和6个月进行放射照相观察,以评估骨填充量。观察者对随访时间和手术过程均视而不见。结果:所有患者的伤口愈合均无异常。移植部位的临床附着水平和骨形成明显高于对照部位。两个中心均显示相似的骨形成。结论:这项多中心的初步研究结果显示,EHA的结果令人鼓舞。与对照组相比,观察到骨形成的增强。 EHA将成为一种经济,安全的合成材料,可用于颌面部骨骼的移植。 EHA的制备过程正在走向绿色。蛋壳废料是生产EHA的有价值的原料,具有成本效益,并且没有疾病转移的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号